title: Tailored immunosuppression: the way we should follow?
authors.affiliation: Cardiology, University Hospital Bern, Bern, Switzerland. paul.mohacsi@insel.ch
authors.forename: P
authors.initials: P
authors.lastname: Mohacsi
authors.forename: J
authors.initials: J
authors.lastname: Schmidli
authors.forename: R
authors.initials: R
authors.lastname: Hullin
authors.forename: M
authors.initials: M
authors.lastname: Stalder
authors.forename: T
authors.initials: T
authors.lastname: Carrel
mesh_terms: D015510:Clinical Medicine; D019317:Evidence-Based Medicine; D006084:Graft Rejection / Q000145:classification* / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017211:Treatment Failure
chemical_list: D007166:Immunosuppressive Agents